Show
Sort by
-
- Journal Article
- A1
- open access
IDO expression in cancer : different compartment, different functionality?
-
Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma
-
Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma
-
- Journal Article
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response